• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于评估医学诊断试验的诊断似然比的回归建模。

Regression modelling of diagnostic likelihood ratios for the evaluation of medical diagnostic tests.

作者信息

Leisenring W, Pepe M S

机构信息

Program in Clinical Statistics, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, USA.

出版信息

Biometrics. 1998 Jun;54(2):444-52.

PMID:9629638
Abstract

The use of diagnostic likelihood ratios has been advocated in the epidemiologic literature for the past decade. Diagnostic likelihood ratios provide valuable information about the predictive properties of a diagnostic test while having the attractive feature of being independent of the prevalence of disease in the study population. We propose a new regression method that allows for direct assessment of covariate effects on likelihood ratios for binary diagnostic tests. This may be particularly useful in assessing how factors that are under the control of the clinician can be altered to maximize the predictive ability of the test. Similarly, patient characteristics that influence the ability of the test to discriminate between diseased and nondiseased subjects may be identified using the regression model. The regression method is flexible in that it can accommodate clustered data arising from a variety of study designs. We illustrate the method with data from an audiology study.

摘要

在过去十年中,流行病学文献一直提倡使用诊断似然比。诊断似然比提供了有关诊断测试预测特性的有价值信息,同时具有独立于研究人群中疾病患病率的吸引人的特点。我们提出了一种新的回归方法,该方法允许直接评估协变量对二元诊断测试似然比的影响。这在评估如何改变临床医生可控制的因素以最大化测试的预测能力方面可能特别有用。同样,可以使用回归模型识别影响测试区分患病和未患病受试者能力的患者特征。该回归方法具有灵活性,因为它可以适应来自各种研究设计的聚类数据。我们用一项听力学研究的数据说明了该方法。

相似文献

1
Regression modelling of diagnostic likelihood ratios for the evaluation of medical diagnostic tests.用于评估医学诊断试验的诊断似然比的回归建模。
Biometrics. 1998 Jun;54(2):444-52.
2
Comparison of the likelihood ratios of two binary diagnostic tests in paired designs.配对设计中两种二元诊断试验似然比的比较。
Stat Med. 2007 Sep 30;26(22):4179-201. doi: 10.1002/sim.2850.
3
New patient-oriented diagnostic test characteristics analogous to the likelihood ratios conveyed information on trustworthiness.类似于似然比的以患者为导向的新诊断测试特征传达了有关可信度的信息。
J Clin Epidemiol. 2005 May;58(5):450-7. doi: 10.1016/j.jclinepi.2004.07.009.
4
Modelling risk when binary outcomes are subject to error.二分类结局存在误差时的风险建模。
Stat Med. 2004 Apr 15;23(7):1095-109. doi: 10.1002/sim.1656.
5
The diagnostic utility of multiple-level likelihood ratios.多级似然比的诊断效用。
J Int Neuropsychol Soc. 2009 Sep;15(5):769-76. doi: 10.1017/S1355617709990373. Epub 2009 Jul 28.
6
[Criteria for evaluating the performance and utility of a diagnostic test].[诊断试验性能和效用的评估标准]
Med Trop (Mars). 2009 Feb;69(1):78-82.
7
Meta-analysis of diagnostic accuracy studies accounting for disease prevalence: alternative parameterizations and model selection.考虑疾病患病率的诊断准确性研究的Meta分析:替代参数化和模型选择。
Stat Med. 2009 Aug 15;28(18):2384-99. doi: 10.1002/sim.3627.
8
Repeated-measures modeling improved comparison of diagnostic tests in meta-analysis of dependent studies.重复测量模型改善了相关性研究的荟萃分析中诊断试验的比较。
J Clin Epidemiol. 2004 Jul;57(7):698-711. doi: 10.1016/j.jclinepi.2003.12.007.
9
Estimating treatment efficacy over time: a logistic regression model for binary longitudinal outcomes.评估随时间变化的治疗效果:用于二元纵向结局的逻辑回归模型
Stat Med. 2005 Sep 30;24(18):2789-805. doi: 10.1002/sim.2147.
10
Bayesian latent class models with conditionally dependent diagnostic tests: a case study.具有条件依赖诊断测试的贝叶斯潜在类别模型:一项案例研究。
Stat Med. 2008 Sep 30;27(22):4469-88. doi: 10.1002/sim.3317.

引用本文的文献

1
Development and validation of clinical prediction score for mortality in tuberculosis patients.结核病患者死亡率临床预测评分的开发与验证
Narra J. 2025 Aug;5(2):e1701. doi: 10.52225/narra.v5i2.1701. Epub 2025 Apr 21.
2
Challenges in developing and validating machine learning models for TAVI mortality risk prediction: reply.开发和验证用于经导管主动脉瓣植入术(TAVI)死亡率风险预测的机器学习模型面临的挑战:回复
Eur Heart J Digit Health. 2023 Nov 8;5(1):3-5. doi: 10.1093/ehjdh/ztad065. eCollection 2024 Jan.
3
Development and internal validation of simplified predictive scoring (ICU-SEPSA score) for mortality in patients with multidrug resistant infection.
多重耐药感染患者死亡率简化预测评分(ICU-SEPSA评分)的开发与内部验证
Front Pharmacol. 2022 Aug 26;13:938028. doi: 10.3389/fphar.2022.938028. eCollection 2022.
4
Developing breast lesion detection algorithms for digital breast tomosynthesis: Leveraging false positive findings.开发数字乳腺断层合成中的乳腺病变检测算法:利用假阳性发现。
Med Phys. 2022 Dec;49(12):7596-7608. doi: 10.1002/mp.15883. Epub 2022 Aug 19.
5
Novel Clinical Risk Scoring Model for Predicting Amputation in Patients With Necrotizing Fasciitis: The ANF Risk Scoring System.用于预测坏死性筋膜炎患者截肢情况的新型临床风险评分模型:ANF风险评分系统。
Front Med (Lausanne). 2021 Nov 19;8:719830. doi: 10.3389/fmed.2021.719830. eCollection 2021.
6
Compbdt: an R program to compare two binary diagnostic tests subject to a paired design.Compbdt:一个用于比较配对设计下两种二分类诊断试验的 R 程序。
BMC Med Res Methodol. 2020 Jun 5;20(1):143. doi: 10.1186/s12874-020-00988-y.
7
Hearing loss screening tool (COBRA score) for newborns in primary care setting.基层医疗环境中新生儿听力损失筛查工具(COBRA评分)
Korean J Pediatr. 2017 Nov;60(11):353-358. doi: 10.3345/kjp.2017.60.11.353. Epub 2017 Nov 27.
8
A general latent class model for performance evaluation of diagnostic tests in the absence of a gold standard: an application to Chagas disease.无金标准情况下诊断试验性能评估的通用潜在类别模型:在恰加斯病中的应用。
Comput Math Methods Med. 2012;2012:487502. doi: 10.1155/2012/487502. Epub 2012 Jul 31.
9
A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study.一项关于在意义不明确的非典型鳞状细胞-低级别鳞状上皮内病变分流研究中进行Amplicor人乳头瘤病毒DNA检测的研究。
Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1341-9. doi: 10.1158/1055-9965.EPI-08-1180.
10
Estimating the capacity for improvement in risk prediction with a marker.评估利用一个标志物改善风险预测的能力。
Biostatistics. 2009 Jan;10(1):172-86. doi: 10.1093/biostatistics/kxn025. Epub 2008 Aug 19.